Skip to main content
Caplight Logo









InfraScan

InfraScan

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://infrascanner.com/

Last Round

Grant

Jul 21, 2021

Total Funding Raised

$25.83M

Company Overview

InfraScan is a medical device company that develops, commercializes, and distributes portable brain scanners for head injury and stroke assessment based on near-infrared (NIR) technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Defense Tech, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

medical devicenear-infrared spectroscopyNIRSintracranial hematoma detectortraumatic brain injuryTBIpoint of care diagnosticsportable medical scannerfield trauma kitcombat casualty caretriage toolemergency medical equipmentdisposable medical sensorshead trauma screeningmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InfraScan Comparables

Compare InfraScan with similar companies based on industry and business-model similarity.

InfraScan comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ArcheOptix Biomedical
91%
Sense Neuro Diagnostics
83%
AiimSense Inc.
83%

InfraScan Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 21, 2021
GrantJun 17, 2021
GrantMay 7, 2021
GrantOct 9, 2017
GrantOct 1, 2014
Series A
Dec 1, 2011

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 73% MoM, reaching 2.4K.

  • Jun 1, 2025

    Monthly visitors increased 33% MoM.

InfraScan Filings

Explore SEC and related filing metadata, where available.

InfraScan filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InfraScan's valuation, stock price, and market status.

Is InfraScan a public or private company?

InfraScan is a private company.

What is the current stock price of InfraScan?

InfraScan is a private company, so its shares have no public market price. Caplight tracks InfraScan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is InfraScan worth (valuation)?

Valuation information for InfraScan is not publicly available.

Can I buy InfraScan stock?

InfraScan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was InfraScan's last funding round?

InfraScan's most recent funding round was Grant on July 21, 2021.

Who are the main investors in InfraScan?

Key investors in InfraScan include BioAdvance Capital.

Will InfraScan IPO soon?

No public IPO plans have been announced for InfraScan.

How can I track InfraScan secondary market activity?

Caplight tracks bids, offers, and trades in InfraScan's shares on secondary markets.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range8
Year Founded2004
Last FundingJul 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?